The India Cements (INDIACEM) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
8 Jul, 2026Executive summary
Cement demand remained steady, supported by increased government CapEx, with 2,108 km of highways built in Q1 FY26, up 8.9% YOY.
Domestic sales volume reached 2.18 MnT in Q1 FY26, marking an 11.6% year-over-year increase.
Consolidated volume growth was 9.7% YOY, including Kesoram, with effective management of Kesoram from March 2025 and India Cements from December 2024.
Urban housing showed signs of rebound, while rural markets are expected to grow favorably in coming quarters.
EBITDA per metric ton rose sharply to ₹424 from ₹88 in Q4 FY25.
Financial highlights
Realizations for UltraTech brand increased 2.2% sequentially; UltraTech plus Kesoram saw a 2.3% increase.
Net sales for Q1 FY26 were ₹1,025 crore, nearly flat year-over-year.
EBITDA improved to ₹92 crore from a loss of ₹9 crore in Q1 FY25.
CapEx during the quarter was around INR 2,000 crores, excluding India Cements.
Average cost of borrowing was 7% for the previous quarter, expected to decline with further rate cuts.
Outlook and guidance
Double-digit volume growth targeted for FY26, with new capacities and integration of acquisitions supporting this.
Planned capex for productivity and energy efficiency is expected to yield benefits starting Q4 FY27.
Green power (RE + WHRS) targeted to scale from 5% to 86% by FY27.
India Cements expected to reach EBITDA per ton in excess of INR 1,000 by FY28 after CapEx and integration.
Profitability is expected to improve as capex benefits and synergies from the holding company materialize.
Latest events from The India Cements
- Q1 FY27 delivered double-digit volume growth, record EBITDA, and stable financial health.INDIACEM
Q1 26/2720 Jul 2026 - Sales and margins improved, with restructuring and expansion amid ongoing legal risks.INDIACEM
Q2 25/269 Jul 2026 - Record capacity, robust growth, higher dividends, and restructuring amid legal and cost headwinds.INDIACEM
Q4 25/2628 Apr 2026 - Sales up 25% YoY, revenue higher, but net losses persist amid cost and legal risks.INDIACEM
Q3 25/2613 Apr 2026 - Profitability returned in Q1 FY25 on an exceptional gain, with major stake sale to UltraTech Cement.INDIACEM
Q1 24/251 Sep 2025 - Losses widened on lower revenue, with major asset sales and a pending UltraTech acquisition.INDIACEM
Q2 24/251 Sep 2025 - Q3 FY25 saw lower revenue, major losses, UltraTech's takeover, and large asset revaluation gains.INDIACEM
Q3 24/251 Sep 2025 - FY25 saw deeper losses, lower revenue, and major legal disputes, with auditors' unmodified opinions.INDIACEM
Q4 24/251 Sep 2025